Gene Technology: Stem Cell and Leukemia Research (Nato ASI Subseries H:). Este artículo no está disponible.Gene Technology: Stem Cell and Leukemia Research (Nato ASI Subseries H:)

This text covers both somatic gene therapy of inherited human diseases as well as of cancer, with emphasis on malignancies of the haematopoietic system. Topics include the isolation and development of haematopietic stem cells, genes involved in development and diseases, methods of gene transfer, carrying out gene transfer, oncogenes and antioncogenes as targets for gene therapy, receptors and their ligands in normal development and diseases, immunology and immunotherapy, radiation biology, clinical leukaemias and bone marrow transplantation

The 11 th meeting in "Modern Trends in Human Leukemia" took place from June 19 to 21, 1994 in Wilsede in the middle of the Liineburger Heide, South of Hamburg. Interwoven with the Leukemia program was the Nato-sponsored Symposium of the ASI-Series "Gene Technology in Analysis of Malignant and Inherited Human Diseases Related to Development" . The Wilsede meeting was continued on a ship of the Neva leading through lake Ladoga and lake Onega. The topics of both meetings included discussion on recent progress isolation and development of hematopoietic stem cells, genes crucial for development and diseases, methods of gene transfer, application of gene transfer; oncogenes and anti-oncogenes as targets for gene therapy; receptors and their ligands in normal development and diseases, immunology and immunotherapy, radiation biology, clinical leukemias and bone marrow transplantation. The Nato workshop concentrated not only on analysis of cell systems useful for somatic gene therapy, but also on actual themes directly related to correction of human diseases. The latter aspects emphasized themes related to biotechnology, the first part was by nature more general. We also included a few contributions that discussed perspectives for the future of gene therapy and possible relationships to evolution.